Department of Urology, Deaconesses-Croix St Simon Medical Center, 12-18 rue du Sergent Bauchat, 75102 Paris, France.
Nat Rev Urol. 2012 Aug;9(8):414-5. doi: 10.1038/nrurol.2012.133. Epub 2012 Jun 26.
High-intensity focused ultrasound (HIFU) represents a fairly new treatment option for focal therapy of prostate cancer. However, studies evaluating its efficacy have not provided strong data to support the use of HIFU in the majority of patients. Thus, high-profile studies investigating feasibility of the modality in terms of adverse effects seem premature.
高强度聚焦超声（HIFU）是一种治疗前列腺癌的新方法。然而，评估其疗效的研究并未提供强有力的数据支持在大多数患者中使用 HIFU。因此，研究该方法在不良影响方面的可行性的高知名度研究似乎为时过早。
